亚洲精品国产AV成拍色拍个_国产欧美日韩人成在线观看_欧美理论在线观看_最近在线观看免费完整视频_成人a亚洲精v品无码国产_亚洲情无码AV蜜桃_99成人 国产精品视频_樱花一级毛片免费播放_影音先锋欧美日韩_色天堂AV女优在线

2022 Singuway

Review of major events throughout the year

In 2022, the COVID-19 epidemic is delayed and repeated, geopolitical differences are increasingly intensified, the global economic recovery is fragile and tortuous, and large-scale natural disasters cause heavy losses... Facing many challenges, it is destined to be another unforgettable and extraordinary year, and the fifth year has passed Singuway strives to find solutions and hope for a better future for mankind.

January

In 2022, the COVID-19 epidemic will enter its third year. The epidemic has directly or indirectly caused more than 20 million deaths. Global health systems are overwhelmed and many essential health services have been disrupted, posing a major threat to progress against other deadly diseases. Singuway's COVID-19 diagnosis business has achieved substantial growth, contributing to the global epidemic prevention and control.

February

After the new year, Singuway faces the new year with a new business structure, product planning, and market strategy.

March

Singuway's new series of nucleic acid detection kits are on the market, and Singuway's blockbuster products in the detection field: hepatitis B virus, hepatitis C virus, human immunodeficiency virus (type 1), COVID-19, influenza A virus andinfluenza B, high-risk human papillomavirus (HPV), and human MTHFR gene polymorphism detection kit (PCR-fluorescence method) was successfully launched.

April

Singuway has launched a new generation of AutoGuard 96A automatic nucleic acid extractor, which integrates a large number of pre-treatment steps that require manual operation into a closed system, and completes the entire process of nucleic acid extraction in batches. It can be unattended to complete the whole process of nucleic acid extraction after the original tube is put on the machine. It is widely used in the nucleic acid extraction of virus storage tubes such as respiratory tract and intestinal tract, and provides assistance for clinical testing institutions and related laboratories. In the same month, Cellcount-60, a five part hematology analyzer, was launched.

May

Successfully participated in the Hospitalar exhibition in Sao Paulo, Brazil, and received customers from the Americas and even the world with a warm and professional attitude, and the globalization service has gone a step further.

June

The AccuRa-32 real-time fluorescent PCR instrument was released on the market. The AccuRa-32 real-time fluorescent PCR instrument developed by Singuway can realize real-time and high-sensitivity fluorescence measurement for the pain points such as the lack of molecular testing personnel, the surge in detection volume, low detection efficiency, and cumbersome procedures. , can be freely matched with the experiment, to realize the independent operation of two different programs, and to detect 32 samples at the same time.

July

Singuway Biotech Inc. won the honorary title in Shenzhen for its excellent medical device research and development capabilities, independent innovation capabilities, and high-performance reagents and research and development products.

August

Singuway's raw material products are on the market, and the targeted application directions include molecular diagnosis and so on.

September

Singuway carries out the detection of pathogenic microorganisms of livestock, poultry and aquatic animal diseases, and has established more than 70 detection kits for major animal diseases, zoonotic diseases, and aquatic animal diseases. Singuway has played an irreplaceable role in protecting biological safety.

October

Singuway's new series of nucleic acid detection kits were launched, and Singuway's blockbuster products in the detection field: Mycobacterium tuberculosis, Plasmodium falciparum, adenovirus, Zika virus, Chlamydia trachomatis, Neisseria gonorrhoeae, Ureaplasma urealyticum detection kit (PCR -Fluorescence method) Trial production successfully launched.

November

In 2022, Singuway will bring its products to various global industry exhibitions such as MEDICA in Germany and CMEF in Shenzhen, and conduct in-depth communication with medical colleagues from all over the world to achieve win-win cooperation and look forward to the future.

December

The layout of Singuway's overseas market has achieved initial results. Sales channels have been established in Asia, Africa, America and Europe. The products are exported to more than 50 countries and regions overseas, and have passed a number of international certifications, achieving rapid breakthroughs More and more Singuway products have appeared on the international stage and have been widely recognized.

In 2023, let us continue to stay true to our original aspirations, live up to our love.